טוען...
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge
The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number of patients needing mechanical ventilation or intensive care units treatment and for the elevated mortality risk. A link between C...
שמור ב:
| הוצא לאור ב: | Thromb Haemost |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Georg Thieme Verlag KG
2020
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7295290/ https://ncbi.nlm.nih.gov/pubmed/32349133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1710317 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|